627
Views
5
CrossRef citations to date
0
Altmetric
Biochemistry & Molecular Biology

Inhibition of melanin production and promotion of collagen production by the extract of Kuji amber

, , , &
Pages 518-525 | Received 29 Aug 2019, Accepted 06 Nov 2019, Published online: 22 Nov 2019

References

  • Kimura K Studies of novel bioprobes isolated from rare natural sources using mutant yeasts. J Antibiot (Rev). 2019;72:579–589.
  • Shitamukai A, Mizunuma M, Hirata D, et al. A positive screening for drugs that specifically inhibit the Ca2+-signaling activity on the basis of the growth promoting effect on a yeast mutant with a peculiar phenotype. Biosci Biotechnol Biochem. 2000;64:1942–1946.
  • Ogasawara Y, Yoshida J, Shiono Y, et al. New eremophilane sesquiterpenoid compounds, eremoxylarins A and B directly inhibit calcineurin in a manner independent of immunophilin. J Antibiot. 2008;61:496–502.
  • Kimura K, Minamikawa Y, Ogasawara Y, et al. Kujigamberol, a new dinorlabdane diterpenoid isolated from 85 million years old Kuji amber using a biotechnological assay. Fitoterapia. 2012;83:907–912.
  • Ye YQ, Koshino H, Hashizume D, et al. Synthesis and biological activity of both enantiomers of kujigamberol isolated from 85-million-years-old Kuji amber. Bioorg Med Chem Lett. 2012;22:4259–4262.
  • Uchida T, Koshino H, Takahashi S, et al. Ca2+-Signal transduction inhibitors, kujiol A and kujigamberol B, isolated from Kuji amber using a mutant yeast. J Nat Prod. 2018;81:1070–1074.
  • Shimizu E, Koshino H, Noro A, et al. Isolation of a spirolactone norditerpenoid as a yeast Ca2+ signal transduction inhibitor from Kuji amber and evaluation of its effects on PPM1A activity. Fitoterapia. 2019;134:290–296.
  • Takahashi H, Koshino H, Maruyama M, et al. A novel Ca2+-signal transduction inhibitor, kujigamberol C, isolated from Kuji amber. Biosci Biotechnol Biochem. 2019; 83: 1630–1634.
  • Takahashi H, Shimoda N, Koshino H, et al.Kujigamberoic acid A, a carboxylic acid derivative of kujigamberol, has potent inhibitory activity against the degranulation of RBL-2H3 cells. Biosci Biotechnol Biochem 2019;83:1193–1196.
  • Kawamura T, Koshino H, Nakamura T, et al. Amberene and 1-methylamberene, isolated and identified from Kuji amber (Japan). Org Geochem. 2018;120:12–18.
  • Maruyama M, Kobayashi M, Uchida T, et al. Anti-allergy activities of Kuji amber extract and kujigamberol. Fitoterapia. 2018;127:263–270.
  • Fukuhara S, Tanigaki R, Kimura K, et al., Kujigamberol interferes with pro-inflammatory cytokine-induced expression of and N-glycan modifications to cell adhesion molecules at different stages in human umbilical vein endothelial cells. Int Immunopharmacol. 2018;62:313–325.
  • Choi JS, Jeon MH, Moon WS, et al. In vivo hair growth-promoting effect of rice bran extract prepared by supercritical carbon dioxide fluid. Biol Pharm Bull. 2014;37:44–53.
  • Khaw KY, Parat MO, Shaw PN, et al. Solvent supercritical fluid technologies to extract bioactive compounds from natural sources: a review. Molecules. 2017;22:1186.
  • Chung SY, Seo YK, Park JM, et al. Fermented rice bran downregulates MITF expression and leads to inhibition of alpha-MSH-induced melanogenesis in B16F1 melanoma. Biosci Biotechnol Biochem. 2009;73:1704–1710.
  • Yoshida I, Ito C, Matsuda S, et al. Alisol B, a triterpene from Alismatis rhizoma (dried rhizome of Alisma orientale), inhibits melanin production in murine B16 melanoma cells. Biosci Biotechnol Biochem. 2017;81:534–540.
  • Deglesne PA, Arroyo R, Fidalgo López J, et al. In vitro study of RRS® Silisorg CE class III medical device composed of silanol: effect on human skin fibroblasts and its clinical use. Med Devices (Auckl). 2018;11:313–320.
  • Ohguchi K, Ito M, Yokoyama K, et al. Effects of sesquiterpene lactones on melanogenesis in mouse B16 melanoma cells. Biol Pharm Bull. 2009;32:308–310.
  • Kim Y, Lee S, Ryu JH, et al. Effect of aurea helianthus stem extract on anti-melanogenesis. Biosci Biotechnol Biochem. 2018;82:1871–1879.
  • Ochiai A, Tanaka S, Tanaka T, et al. Rice bran protein as a potent source of antimelanogenic peptides with tyrosinase inhibitory activity. J Nat Prod. 2016;79:2545–2551.
  • Fang QQ, Wang XF, Zhao WY, et al. Angiotensin-converting enzyme inhibitor reduces scar formation by inhibiting both canonical and noncanonical TGF-β1 pathways. Sci Rep. 2018;8:3332.
  • Lee SY, Baek N, Nam TG Natural, semisynthetic and synthetic tyrosinase inhibitors. J Enzyme Inhib Med Chem. 31;2016:1–13.
  • Seo DH, Jung JH, Lee JE, et al. Biotechnological production of arbutins (α- and β-arbutins), skin-lightening agents, and their derivatives, Appl Microbiol Biotechnol. 2012;95:1417–1425.
  • Luck MR, Jeyaseelan I, Scholes RA Ascorbic acid and fertility. Biol Reprod. 1995;52:262–266.
  • Nabzdyk CS, Bittner EA Vitamin C in the critically ill - indications and controversies, World J Crit Care Med. 2018;7:52–61.
  • Mann T, Gerwat W, Batzer J, et al. Inhibition of human tyrosinase requires molecular motifs distinctively different from mushroom tyrosinase. J Invest Dermatol. 2018;138:1601–1608.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.